(Q37515355)

20 August 2017

1 reference

title

Molecular characterization and classification of neuroblastoma (English)

1 reference

20 August 2017

André Oberthuer

1

1 reference

20 August 2017

Jessica Theissen

2

1 reference

20 August 2017

Frank Westermann

3

1 reference

20 August 2017

Barbara Hero

4

1 reference

20 August 2017

Matthias Fischer

5

1 reference

20 August 2017

language of work or name

English

0 references

publication date

1 June 2009

1 reference

20 August 2017

1 reference

20 August 2017

volume

5

1 reference

20 August 2017

issue

5

1 reference

20 August 2017

page(s)

625-639

1 reference

Neuroblastoma: biology and molecular and chromosomal pathology

20 August 2017

cites work

1 reference

Neuroblastoma: biological insights into a clinical enigma

21 January 2018

1 reference

The biologic basis for neuroblastoma heterogeneity and risk stratification

21 January 2018

1 reference

Screening of infants and mortality due to neuroblastoma

21 January 2018

1 reference

A proposed staging for children with neuroblastoma.Children's cancer study group A

21 January 2018

1 reference

Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage

21 January 2018

1 reference

Chromosome 1p and 11q deletions and outcome in neuroblastoma

21 January 2018

1 reference

Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma

21 January 2018

1 reference

The tumor-associated antigen PRAME is universally expressed in high-stage neuroblastoma and associated with poor outcome

21 January 2018

1 reference

Overall genomic pattern is a predictor of outcome in neuroblastoma

21 January 2018

1 reference

Expression profiling using a tumor-specific cDNA microarray predicts the prognosis of intermediate risk neuroblastomas.

21 January 2018

1 reference

Prognostic significance of gene expression profiles of metastatic neuroblastomas lacking MYCN gene amplification

21 January 2018

1 reference

Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour

21 January 2018

1 reference

Pathology and biology guidelines for resectable and unresectable neuroblastic tumors and bone marrow examination guidelines

21 January 2018

1 reference

MYCN-status in neuroblastoma: characteristics of tumours showing amplification, gain, and non-amplification.

21 January 2018

1 reference

Reduced expression of CAMTA1 correlates with adverse outcome in neuroblastoma patients

21 January 2018

1 reference

Expression of the tumour suppressor gene CADM1 is associated with favourable outcome and inhibits cell survival in neuroblastoma

21 January 2018

1 reference

MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells

21 January 2018

1 reference

Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors

21 January 2018

1 reference

Unequivocal delineation of clinicogenetic subgroups and development of a new model for improved outcome prediction in neuroblastoma

21 January 2018

1 reference

High-resolution analysis of chromosomal breakpoints and genomic instability identifies PTPRD as a candidate tumor suppressor gene in neuroblastoma

21 January 2018

1 reference

Novel risk stratification of patients with neuroblastoma by genomic signature, which is independent of molecular signature.

21 January 2018

1 reference

Inferring a tumor progression model for neuroblastoma from genomic data

21 January 2018

1 reference

Identification of candidate genes involved in neuroblastoma progression by combining genomic and expression microarrays with survival data.

21 January 2018

1 reference

Oncogenic mutations of ALK kinase in neuroblastoma

21 January 2018

1 reference

Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma

21 January 2018

1 reference

Identification of ALK as a major familial neuroblastoma predisposition gene

21 January 2018

1 reference

Subclassification and individual survival time prediction from gene expression data of neuroblastoma patients by using CASPAR.

21 January 2018

1 reference

Biological role of anaplastic lymphoma kinase in neuroblastoma

21 January 2018

1 reference

Germline PHOX2B mutation in hereditary neuroblastoma

21 January 2018

1 reference

Germline mutations of the paired-like homeobox 2B (PHOX2B) gene in neuroblastoma

21 January 2018

1 reference

Chromosome 6p22 locus associated with clinically aggressive neuroblastoma

21 January 2018

1 reference

Survivin mRNA levels are associated with biology of disease and patient survival in neuroblastoma: a report from the children's oncology group

21 January 2018

1 reference

repp86 Expression and Outcome in Patients With Neuroblastoma

21 January 2018

1 reference

N-myc enhances the expression of a large set of genes functioning in ribosome biogenesis and protein synthesis

21 January 2018

1 reference

Prediction of clinical outcome using gene expression profiling and artificial neural networks for patients with neuroblastoma

21 January 2018

1 reference

Diagnosis of multiple cancer types by shrunken centroids of gene expression

21 January 2018

1 reference

CASPAR: a hierarchical bayesian approach to predict survival times in cancer from gene expression data

21 January 2018

1 reference

Excellent outcome with reduced treatment for infants with disseminated neuroblastoma without MYCN gene amplification

21 January 2018

1 reference

Metastatic neuroblastoma in infancy: what does the pattern of metastases contribute to prognosis?

21 January 2018

1 reference

Prediction of clinical outcome and biological characterization of neuroblastoma by expression profiling.

21 January 2018

1 reference

Differential expression of neuronal genes defines subtypes of disseminated neuroblastoma with favorable and unfavorable outcome

21 January 2018

1 reference

Specific gene expression profiles and chromosomal abnormalities are associated with infant disseminated neuroblastoma

21 January 2018

1 reference

Cell cycle regulation targets of MYCN identified by gene expression microarrays

21 January 2018

1 reference

Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas

21 January 2018

1 reference

High Myc pathway activity and low stage of neuronal differentiation associate with poor outcome in neuroblastoma

21 January 2018

1 reference

Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a randomised controlled trial

21 January 2018

1 reference

Oncogenic pathway signatures in human cancers as a guide to targeted therapies

21 January 2018

1 reference

Stabilization of N-Myc is a critical function of Aurora A in human neuroblastoma

21 January 2018

1 reference

RNA-Seq: a revolutionary tool for transcriptomics

21 January 2018

1 reference

Analyzing proteome topology and function by automated multidimensional fluorescence microscopy

21 January 2018

1 reference

Neuroblastoma Screening at One Year of Age

21 January 2018

1 reference

Customized Oligonucleotide Microarray Gene Expression–Based Classification of Neuroblastoma Patients Outperforms Current Clinical Risk Stratification

21 January 2018

1 reference

Evidence for an Age Cutoff Greater Than 365 Days for Neuroblastoma Risk Group Stratification in the Children's Oncology Group

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/FON.09.41

1 reference

20 August 2017

1 reference